nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Loose stools—Auranofin—psoriatic arthritis	0.0572	0.0572	CcSEcCtD
Telbivudine—Hepatitis acute—Methotrexate—psoriatic arthritis	0.0423	0.0423	CcSEcCtD
Telbivudine—Neutropenia—Auranofin—psoriatic arthritis	0.0186	0.0186	CcSEcCtD
Telbivudine—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.0174	0.0174	CcSEcCtD
Telbivudine—Myopathy—Prednisolone—psoriatic arthritis	0.0144	0.0144	CcSEcCtD
Telbivudine—Hepatomegaly—Prednisolone—psoriatic arthritis	0.0143	0.0143	CcSEcCtD
Telbivudine—Dysgeusia—Auranofin—psoriatic arthritis	0.0136	0.0136	CcSEcCtD
Telbivudine—Myopathy—Triamcinolone—psoriatic arthritis	0.0132	0.0132	CcSEcCtD
Telbivudine—Myopathy—Methylprednisolone—psoriatic arthritis	0.0132	0.0132	CcSEcCtD
Telbivudine—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.0131	0.0131	CcSEcCtD
Telbivudine—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.0131	0.0131	CcSEcCtD
Telbivudine—Myopathy—Betamethasone—psoriatic arthritis	0.012	0.012	CcSEcCtD
Telbivudine—Myopathy—Dexamethasone—psoriatic arthritis	0.012	0.012	CcSEcCtD
Telbivudine—Hepatomegaly—Betamethasone—psoriatic arthritis	0.0119	0.0119	CcSEcCtD
Telbivudine—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.0119	0.0119	CcSEcCtD
Telbivudine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0111	0.0111	CcSEcCtD
Telbivudine—Myopathy—Prednisone—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Telbivudine—Hepatomegaly—Prednisone—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Telbivudine—Dyspepsia—Auranofin—psoriatic arthritis	0.00995	0.00995	CcSEcCtD
Telbivudine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00924	0.00924	CcSEcCtD
Telbivudine—Abdominal pain—Auranofin—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Telbivudine—Pruritus—Auranofin—psoriatic arthritis	0.008	0.008	CcSEcCtD
Telbivudine—Diarrhoea—Auranofin—psoriatic arthritis	0.00773	0.00773	CcSEcCtD
Telbivudine—Vomiting—Auranofin—psoriatic arthritis	0.00719	0.00719	CcSEcCtD
Telbivudine—Rash—Auranofin—psoriatic arthritis	0.00713	0.00713	CcSEcCtD
Telbivudine—Dermatitis—Auranofin—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Telbivudine—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00684	0.00684	CcSEcCtD
Telbivudine—Nausea—Auranofin—psoriatic arthritis	0.00671	0.00671	CcSEcCtD
Telbivudine—Muscular weakness—Prednisolone—psoriatic arthritis	0.00647	0.00647	CcSEcCtD
Telbivudine—Abdominal distension—Prednisolone—psoriatic arthritis	0.00638	0.00638	CcSEcCtD
Telbivudine—Sepsis—Prednisone—psoriatic arthritis	0.00637	0.00637	CcSEcCtD
Telbivudine—Migraine—Betamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Telbivudine—Migraine—Dexamethasone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Telbivudine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00595	0.00595	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Telbivudine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Telbivudine—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00587	0.00587	CcSEcCtD
Telbivudine—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00585	0.00585	CcSEcCtD
Telbivudine—Influenza—Triamcinolone—psoriatic arthritis	0.00583	0.00583	CcSEcCtD
Telbivudine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00542	0.00542	CcSEcCtD
Telbivudine—Muscular weakness—Betamethasone—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Telbivudine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Telbivudine—Sepsis—Methotrexate—psoriatic arthritis	0.00532	0.00532	CcSEcCtD
Telbivudine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Telbivudine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00508	0.00508	CcSEcCtD
Telbivudine—Muscular weakness—Prednisone—psoriatic arthritis	0.0047	0.0047	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.0047	0.0047	CcSEcCtD
Telbivudine—Abdominal distension—Prednisone—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Telbivudine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Telbivudine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Telbivudine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Telbivudine—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Telbivudine—Neutropenia—Prednisone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Telbivudine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Telbivudine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Telbivudine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Telbivudine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00402	0.00402	CcSEcCtD
Telbivudine—Malaise—Prednisolone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Telbivudine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Telbivudine—Back pain—Triamcinolone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Telbivudine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Telbivudine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Telbivudine—Discomfort—Prednisolone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Telbivudine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Telbivudine—Malaise—Triamcinolone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Telbivudine—Malaise—Methylprednisolone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Telbivudine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Telbivudine—Neutropenia—Methotrexate—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Telbivudine—Cough—Triamcinolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Telbivudine—Myalgia—Triamcinolone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Telbivudine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Telbivudine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Telbivudine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Telbivudine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Telbivudine—Discomfort—Triamcinolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Telbivudine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Telbivudine—Renal failure—Methotrexate—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Telbivudine—Malaise—Dexamethasone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Telbivudine—Malaise—Betamethasone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Telbivudine—Insomnia—Prednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Telbivudine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Telbivudine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Telbivudine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Telbivudine—Malnutrition—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Telbivudine—Myalgia—Dexamethasone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Telbivudine—Myalgia—Betamethasone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Telbivudine—Discomfort—Betamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Telbivudine—Discomfort—Dexamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Telbivudine—Pain—Prednisolone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Telbivudine—Insomnia—Triamcinolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Telbivudine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Telbivudine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Telbivudine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Telbivudine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Telbivudine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Telbivudine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Telbivudine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Telbivudine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Telbivudine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Telbivudine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Telbivudine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Telbivudine—Malaise—Prednisone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Telbivudine—Fatigue—Triamcinolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Telbivudine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Telbivudine—Pain—Triamcinolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Telbivudine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Telbivudine—Arthralgia—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Telbivudine—Myalgia—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Telbivudine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Telbivudine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Telbivudine—Insomnia—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Telbivudine—Insomnia—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Telbivudine—Paraesthesia—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Telbivudine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Telbivudine—Discomfort—Prednisone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Telbivudine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Telbivudine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Telbivudine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Telbivudine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Telbivudine—Back pain—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Telbivudine—Fatigue—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Telbivudine—Fatigue—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Telbivudine—Pain—Dexamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Telbivudine—Pain—Betamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Telbivudine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Telbivudine—Skin disorder—Prednisone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Telbivudine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Telbivudine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Telbivudine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Telbivudine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Telbivudine—Malaise—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Telbivudine—Dizziness—Prednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Asthenia—Triamcinolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Telbivudine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Telbivudine—Insomnia—Prednisone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Telbivudine—Paraesthesia—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Telbivudine—Pruritus—Triamcinolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Telbivudine—Cough—Methotrexate—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Telbivudine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Telbivudine—Dyspepsia—Prednisone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Telbivudine—Rash—Prednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Telbivudine—Dermatitis—Prednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Telbivudine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Telbivudine—Fatigue—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Telbivudine—Headache—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Telbivudine—Dizziness—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Telbivudine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Telbivudine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Telbivudine—Asthenia—Betamethasone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Telbivudine—Asthenia—Dexamethasone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Telbivudine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Telbivudine—Nausea—Prednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Telbivudine—Pruritus—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Telbivudine—Pruritus—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Telbivudine—Vomiting—Triamcinolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Telbivudine—Vomiting—Methylprednisolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Telbivudine—Rash—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Telbivudine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Telbivudine—Rash—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Telbivudine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Telbivudine—Headache—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Telbivudine—Headache—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Telbivudine—Body temperature increased—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Telbivudine—Abdominal pain—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Telbivudine—Diarrhoea—Betamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Telbivudine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Telbivudine—Dizziness—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Telbivudine—Dizziness—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Telbivudine—Nausea—Triamcinolone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Telbivudine—Nausea—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Telbivudine—Vomiting—Dexamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Telbivudine—Vomiting—Betamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Telbivudine—Rash—Dexamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Telbivudine—Rash—Betamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Telbivudine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Telbivudine—Dermatitis—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Telbivudine—Headache—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Telbivudine—Headache—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Telbivudine—Asthenia—Prednisone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Telbivudine—Pain—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Telbivudine—Pruritus—Prednisone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Telbivudine—Diarrhoea—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Telbivudine—Nausea—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Telbivudine—Nausea—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Telbivudine—Dizziness—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Telbivudine—Vomiting—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Telbivudine—Rash—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Telbivudine—Dermatitis—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Telbivudine—Headache—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Telbivudine—Nausea—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Telbivudine—Rash—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Telbivudine—Headache—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Telbivudine—Nausea—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
